BrainStorm Cell Therapeutics GAAP EPS of -$2.31
Seeking Alpha News (Mon, 31-Mar 7:05 AM)
- BrainStorm Cell Therapeutics press release (NASDAQ:BCLI): FY GAAP EPS of -$2.31.
- Cash, cash equivalents, and short-term bank deposits were approximately $0.4 million as of December 31, 2024, compared to $1.5 million as of December 31, 2023.
